ICT Health Supports blogg

Our 5 regulatory affairs services - to cover Your entire life cycle of human medicines

Oct 9, 2018 9:34:20 PM / av Patrik Åvestrand

We tailormake our regulatory affairs services, according to your needs; from individual projects to outsourcing of the entire marketing authorization process. Find out how we can support your business in the Nordic countries:

ICT Health Regulatory Affairs

Our highly talented Regulatory Affairs team covers the entire life cycle of human and veterinary medicines. Our team consists of well-experienced regulatory affairs specialists with solid language skills. Continuous training ensures that our team’s knowledge of the relevant legislation is up to date.

From individual projects to outsourcing of the marketing authorization process

  1. We plan, compile and write marketing authorization applications for human and veterinary medicines to all Nordic countries
  2. We maintain marketing authorizations and can help with, for example, variations, renewals, transfer applications and OTC-applications
  3. We prepare and update product information texts (SmPCs, PLs and labelling) for selected Nordic languages together with our translators
  4. We assist you with the registration of herbal products and nutritional additives, as well as cosmetic products.
  5. We perform ethical and medical review of your promotional material

Our experienced Regulatory Affairs experts help you with single projects all the way to handling the entire marketing authorization. Read more about us and our service:

For more information please contact

Patrik Åvestrand
CEO | ICT Health Support
Phone +46 70 204 32 27 | Email: patrik.avestrand@icthealthsupport.se

Laura Riihimäki-Lampén

Regulatory Affairs Team Lead
Email: laura.riihimaki-lampen@oriola.com | Phone: 
+358 50 409 9161

Ämne: Medical Information Service, Regulatoriska tjänster, regulatory services, Oriola, medical review

Patrik Åvestrand

Skriven av Patrik Åvestrand

VD och Grundare av ICT Health Support AB - numera en del av Oriola-koncernen